SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-18-002510
Filing Date
2018-09-12
Accepted
2018-09-12 08:01:39
Documents
15
Period of Report
2018-09-12
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zk1822086.htm 8-K 19702
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 21831
3 EXHIBIT 99.2 exihibit_99-2.htm EX-99.2 27893
4 exhibit_99-1slide1.jpg GRAPHIC 56854
5 exhibit_99-1slide2.jpg GRAPHIC 249441
6 exhibit_99-1slide3.jpg GRAPHIC 53523
7 exhibit_99-1slide4.jpg GRAPHIC 130384
8 exhibit_99-1slide5.jpg GRAPHIC 158418
9 exhibit_99-1slide6.jpg GRAPHIC 101700
10 exhibit_99-1slide7.jpg GRAPHIC 102850
11 exhibit_99-1slide8.jpg GRAPHIC 126762
12 exhibit_99-1slide9.jpg GRAPHIC 131025
13 exhibit_99-1slide10.jpg GRAPHIC 134257
14 exhibit_99-1slide11.jpg GRAPHIC 110493
15 image0.jpg GRAPHIC 8283
  Complete submission text file 0001178913-18-002510.txt   1950421
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Filer) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36621 | Film No.: 181065959
SIC: 2833 Medicinal Chemicals & Botanical Products